H.I.G. logo

 

 

about us
 

H.I.G. Growth Partners is the dedicated growth capital investment affiliate of H.I.G. Capital, a leading global private equity investment firm with over $8.5 billion of capital under management. We seek to make both majority and minority investments in strong, rapidly growing businesses located throughout North America and Europe. We will invest $5 million to $30 million in equity in a given company and target investments in profitable businesses with between $10 million and $100 million in revenues. We consider investments across all industries, but focus on certain high-growth sectors where H.I.G. has extensive in-house expertise such as technology, internet and media, healthcare, consumer products and technology-enabled financial and business services.

As the growth equity investment group within the H.I.G. platform, we are uniquely positioned to add significant value to our businesses by leveraging H.I.G.'s 200 investment professionals and more than 250 investments across a wide range of industries and transactional dynamics. The H.I.G. family of funds includes private equity, growth equity, venture capital, distressed debt, real estate and public equities. H.I.G. has U.S. offices in Atlanta, Boston, Miami, New York and San Francisco as well as European offices in London, Paris and Hamburg.

For more information visit us at www.HIGgrowth.com

 
HIGgrowth.com - All material on this site Copyright © H.I.G. Growth Partners, LLC
H.I.G. logo

 

 

about us
 

H.I.G. BioVentures invests in a broad range of life science opportunities across sectors and stages. Our seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer. We invest in companies developing novel products for significant unmet medical needs, primarily in the following sectors:

  • Therapeutics (small molecules, protein therapeutics, antibodies, etc.)
  • Medical devices
  • Diagnostics

After making an investment, the H.I.G. BioVentures team works closely with portfolio companies in key areas, including:

  • Pre-clinical and clinical development strategy
  • Management recruitment
  • Business development activities
  • Follow on equity and debt financing
  • Achieving liquidity through M&A or IPO

 

For more information visit us at www.higbio.com

 
higbio.com - All material on this site Copyright © H.I.G. BioVentures, LLC